A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome.

ABSTRACT:

SUBMITTER: Bouligny IM 

PROVIDER: S-EPMC12208154 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature